Literature DB >> 9817313

Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall.

A L Poulsen1, T Horn, K Steven.   

Abstract

PURPOSE: We assess the influence of the limits of pelvic lymph node dissection on survival following radical cystectomy for bladder cancer.
MATERIALS AND METHODS: From January 1990 to September 1997, 194 patients underwent radical cystectomy without prior treatment. Between March 1993 and September 1997, 126 consecutive patients underwent radical cystectomy with extended pelvic lymph node dissection beginning at the bifurcation of the aorta, including the common and external iliac vessels, presacral nodes and obturator fossa. Between January 1990 and March 1993, 68 consecutive patients underwent radical cystectomy, with limited pelvic lymph node dissection beginning at the bifurcation of the common iliac vessels, including the external iliac vessels and obturator fossa. The cystectomy procedure remained unchanged throughout this period and 1 surgeon performed all procedures.
RESULTS: A total of 117 patients had tumors confined to the bladder wall (stage pT3a or less) and 77 had tumors penetrating beyond the bladder into perivesical fat or adjacent structures (stage pT3b or greater). The prevalence of patients with tumors penetrating the bladder was higher in the extended dissection group (42.9 versus 33.8% limited dissection). The incidence of lymphatic involvement was 26.2% and slightly higher in the extended than the limited dissection group. There was a modest improvement in the 5-year recurrence-free survival for the extended dissection group (62 versus 56% limited dissection, p = 0.33), and a substantial improvement for the subgroups with tumors confined to the bladder wall (tumor stage pT3a or less) (85 versus 64%, p <0.02) and without lymph node metastasis (stage pT3a or less, pN0) (90 versus 71%, p <0.02). Accordingly, extended pelvic lymph node dissection reduced the 5-year probabilities for pelvic and distant metastasis (2 versus 7% limited dissection, p = 0.17 and 10 versus 21%, p = 0.15, respectively) for patients with tumors confined to the bladder wall (stage pT3a or less). Survival was similar for patients with pT3b or greater tumor.
CONCLUSIONS: This retrospective analysis suggests that extending the limits of pelvic lymph node dissection from the bifurcation of the common iliac vessels to the bifurcation of the aorta improves the recurrence-free survival rate for patients undergoing radical cystectomy for bladder cancer confined to the bladder wall (stage pT3a or less).

Entities:  

Mesh:

Year:  1998        PMID: 9817313

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  55 in total

1.  Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.

Authors:  H Abdi; F Pourmalek; M E Gleave; A I So; P C Black
Journal:  World J Urol       Date:  2015-11-30       Impact factor: 4.226

Review 2.  [Standards and perspectives in diagnosis and therapy of bladder carcinoma].

Authors:  C Stief; D Zaak; M Stöckle; U Studer; R Knuechel; C Rödel; R Sauer; H Rubben
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 3.  Status of robotic cystectomy in 2005.

Authors:  Nicole L Miller; Dan Theodorescu
Journal:  World J Urol       Date:  2006-03-24       Impact factor: 4.226

Review 4.  [Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results].

Authors:  H Suttmann; J Kamradt; F Becker; J Lehmann; M Stöckle
Journal:  Urologe A       Date:  2009-02       Impact factor: 0.639

Review 5.  The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma.

Authors:  Seth P Lerner
Journal:  Curr Treat Options Oncol       Date:  2009-06-30

6.  Surveillance strategies after definitive therapy of invasive bladder cancer.

Authors:  Ilias Cagiannos; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

8.  Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?

Authors:  Magnus Holmer; Pär-Ola Bendahl; Thomas Davidsson; Sigurdur Gudjonsson; Wiking Månsson; Fredrik Liedberg
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

9.  Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.

Authors:  Guru Sonpavde; Bryan H Goldman; V O Speights; Seth P Lerner; David P Wood; Nicholas J Vogelzang; Donald L Trump; Ronald B Natale; H Barton Grossman; E David Crawford
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

10.  Treatment of locally advanced and metastatic bladder cancer.

Authors:  Makarand V Khochikar
Journal:  Indian J Urol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.